Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c02812 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Zhiwei Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Oral and…. Hauptthemen laut MEDLINE: Lymphangiogenesis, Zoledronic Acid, Insulin-Like Growth Factor I, Bisphosphonate-Associated Osteonecrosis of the Jaw. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: West China School of Stomatology, Sichuan University, National Key Research and Development Program of China, Health Commission of Sichuan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan Un…
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, Sichuan China.
Förderung
- West China School of Stomatology, Sichuan University
- National Key Research and Development Program of China
- Health Commission of Sichuan Province
- Science and Technology Department of Sichuan Province
Zitieren
APA
Cao, Z., Zhao, C., Hu, L., Peng, F., Liu, Z., Yang, X., & Pan, J. (2025). Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c02812
Vancouver
Cao Z, Zhao C, Hu L, Peng F, Liu Z, Yang X, et al. Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c02812
BibTeX
@article{Cao2025,
author = {Cao, Zhiwei and Zhao, Chengzhi and Hu, Liru and Peng, Fuli and Liu, Zhanhong and Yang, Xiao and Pan, Jian},
title = {Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c02812}
}
EUVIMED